ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 110 filers reported holding ERASCA INC in Q3 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,779,441 | -28.6% | 11,055,554 | 0.0% | 14.15% | -24.9% |
| Q2 2023 | $30,513,329 | -8.3% | 11,055,554 | 0.0% | 18.84% | +17.3% |
| Q1 2023 | $33,277,218 | -30.2% | 11,055,554 | 0.0% | 16.06% | +31.6% |
| Q4 2022 | $47,649,438 | -44.7% | 11,055,554 | 0.0% | 12.20% | +9.2% |
| Q3 2022 | $86,233,000 | +40.0% | 11,055,554 | 0.0% | 11.18% | +49.0% |
| Q2 2022 | $61,579,000 | -35.2% | 11,055,554 | 0.0% | 7.50% | -44.8% |
| Q1 2022 | $95,078,000 | -44.8% | 11,055,554 | 0.0% | 13.59% | -25.4% |
| Q4 2021 | $172,246,000 | – | 11,055,554 | – | 18.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $21,779,441 | 14.15% |
| EDBI Pte Ltd | 888,888 | $1,751,109 | 1.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,926,000 | $3,794,220 | 1.28% |
| Cormorant Asset Management, LP | 10,813,246 | $21,302,095 | 1.24% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $615,625 | 0.64% |
| Artal Group S.A. | 4,721,194 | $9,301 | 0.40% |
| PFM Health Sciences, LP | 3,930,633 | $7,743,347 | 0.36% |
| ARMISTICE CAPITAL, LLC | 8,356,000 | $16,461,320 | 0.25% |
| SANDERS MORRIS HARRIS LLC | 425,297 | $816,569 | 0.17% |
| Prosight Management, LP | 264,710 | $521,479 | 0.16% |